Diabetes PubMed

Male type 2 diabetic patients undertaking the Ramadan fast can safely maintain glycaemic control with evening administration of gliclazide MR 60 mg during the fast, and reverting to a morning schedule thereafter.

Taken together, the results show that gliclazide may be more useful for the prevention of diabetic vascular complications than glibenclamide.

Three months after replacing rosiglitazone by gliclazide (Diamicron), the visual acuity of the patient improves to 20/40 in the right eye and 20/30 in the left eye.

A combination of gliclazide with metformin achieves good glycemic control and improves lipid levels with better tolerability profile.